Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 3.280
-0.070 (-2.09%)
Apr 30, 2026, 12:37 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 229.32 million as of April 30, 2026. Its market cap has decreased by -32.17% in one year.
Market Cap
229.32M
Enterprise Value
194.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.28
Market Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 229.32M, an increase of 355.29%. That is a compound annual growth rate of 18.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 229.32M | 13.18% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascelia Pharma AB | 372.99M |
| Sprint Bioscience AB | 339.76M |
| Bio-Works Technologies AB | 308.22M |
| Mendus AB | 300.00M |
| Isofol Medical AB | 214.73M |
| Xbrane Biopharma AB | 206.05M |
| Xintela AB | 204.98M |
| Active Biotech AB | 163.44M |